10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2019 | |||
Consolidated Statements of Earnings | |||
Period Ending Dec 29, 2019 10-K (Filed: Feb 18, 2020) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 29, 2019 | Dec 30, 2018 | Dec 31, 2017 | |
| Sales to customers | $ 82,059 | 81,581 | 76,450 |
| Cost of products sold | 27,556 | 27,091 | 25,439 |
| Gross profit | 54,503 | 54,490 | 51,011 |
| Selling, marketing and administrative expenses | 22,178 | 22,540 | 21,520 |
| Research and development expense | 11,355 | 10,775 | 10,594 |
| In-process research and development (Note 5) | 890 | 1,126 | 408 |
| Interest income | (357) | (611) | (385) |
| Interest expense, net of portion capitalized (Note 4) | 318 | 1,005 | 934 |
| Other (income) expense, net | 2,525 | 1,405 | (42) |
| Restructuring (Note 22) | 266 | 251 | 309 |
| Earnings before provision for taxes on income | 17,328 | 17,999 | 17,673 |
| Provision for taxes on income (Note 8) | 2,209 | 2,702 | 16,373 |
| Net earnings | 15,119 | 15,297 | 1,300 |
| Net earnings per share (Notes 1 and 15) | |||
| Basic (in dollars per share) | 5.72 | 5.70 | 0.48 |
| Diluted (in dollars per share) | 5.63 | 5.61 | 0.47 |
| Average shares outstanding (Notes 1 and 15) | |||
| Basic (in shares) | 2,645,100 | 2,681,500 | 2,692,000 |
| Diluted (in shares) | 2,684,300 | 2,728,700 | 2,745,300 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2019 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 29, 2019 10-K (Filed: Feb 18, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 29, 2019 | Dec 30, 2018 | Dec 31, 2017 | |
| Net earnings | $ 15,119 | 15,297 | 1,300 |
| Other Comprehensive Income (Loss), net of tax | |||
| Foreign currency translation | 164 | (1,518) | 1,696 |
| Securities | |||
| Unrealized holding gain (loss) arising during period | 0 | (1) | 159 |
| Reclassifications to earnings | 0 | 1 | (338) |
| Net change | 0 | 0 | (179) |
| Employee benefit plans | |||
| Prior service credit (cost), net of amortization | (18) | (44) | 2 |
| Gain (loss), net of amortization | (714) | (56) | 29 |
| Effect of exchange rates | (1) | 92 | (201) |
| Net change | (733) | (8) | (170) |
| Derivatives & hedges | |||
| Unrealized gain (loss) arising during period | (107) | (73) | (4) |
| Reclassifications to earnings | 7 | (192) | 359 |
| Net change | (100) | (265) | 355 |
| Other comprehensive income (loss) | (669) | (1,791) | 1,702 |
| Comprehensive income | 14,450 | 13,506 | 3,002 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2019 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 29, 2019 10-K (Filed: Feb 18, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 29, 2019 | Dec 30, 2018 | Dec 31, 2017 | |
| Cash flows from operating activities | |||
| Net earnings | $ 15,119 | 15,297 | 1,300 |
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||
| Depreciation and amortization of property and intangibles | 7,009 | 6,929 | 5,642 |
| Stock based compensation | 977 | 978 | 962 |
| Asset write-downs | 1,096 | 1,258 | 795 |
| Gain on sale of assets/businesses | (2,154) | (1,217) | (1,307) |
| Deferred tax provision | (2,476) | (1,016) | 2,406 |
| Accounts receivable allowances | (20) | (31) | 17 |
| Changes in assets and liabilities, net of effects from acquisitions and divestitures: | |||
| Increase in accounts receivable | (289) | (1,185) | (633) |
| (Increase)/Decrease in inventories | (277) | (644) | 581 |
| Increase in accounts payable and accrued liabilities | 4,060 | 3,951 | 2,725 |
| Increase in other current and non-current assets | (1,054) | (275) | (411) |
| Increase/(Decrease) in other current and non-current liabilities | 1,425 | (1,844) | 8,979 |
| Net cash flows from operating activities | 23,416 | 22,201 | 21,056 |
| Cash flows from investing activities | |||
| Additions to property, plant and equipment | (3,498) | (3,670) | (3,279) |
| Proceeds from the disposal of assets/businesses, net | 3,265 | 3,203 | 1,832 |
| Acquisitions, net of cash acquired (Note 20) | (5,810) | (899) | (35,151) |
| Purchases of investments | (3,920) | (5,626) | (6,153) |
| Sales of investments | 3,387 | 4,289 | 28,117 |
| Proceeds from credit support agreements | 338 | 0 | 0 |
| Other | 44 | (464) | (234) |
| Net cash used by investing activities | (6,194) | (3,167) | (14,868) |
| Cash flows from financing activities | |||
| Dividends to shareholders | (9,917) | (9,494) | (8,943) |
| Repurchase of common stock | (6,746) | (5,868) | (6,358) |
| Proceeds from short-term debt | 39 | 80 | 869 |
| Repayment of short-term debt | (100) | (2,479) | (1,330) |
| Proceeds from long-term debt, net of issuance costs | 3 | 5 | 8,992 |
| Repayment of long-term debt | (2,823) | (1,555) | (1,777) |
| Proceeds from the exercise of stock options/employee withholding tax on stock awards, net | 954 | 949 | 1,062 |
| Other | 575 | (148) | (188) |
| Net cash used by financing activities | (18,015) | (18,510) | (7,673) |
| Effect of exchange rate changes on cash and cash equivalents | (9) | (241) | 337 |
| (Decrease)/Increase in cash and cash equivalents | (802) | 283 | (1,148) |
| Cash and cash equivalents, beginning of year (Note 1) | 18,107 | 17,824 | |
| Cash and cash equivalents, end of year (Note 1) | 17,305 | 18,107 | 17,824 |
| Supplemental cash flow data | |||
| Cash paid during the year for: | |||
| Interest | 995 | 1,049 | 960 |
| Interest, net of amount capitalized | 925 | 963 | 866 |
| Income taxes | 4,191 | 4,570 | 3,312 |
| Supplemental schedule of non-cash investing and financing activities | |||
| Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards | 1,736 | 2,095 | 2,062 |
| Conversion of debt | 1 | 6 | 16 |
| Acquisitions | |||
| Fair value of assets acquired | 7,228 | 1,047 | 36,937 |
| Fair value of liabilities assumed and noncontrolling interests | (1,418) | (148) | (1,786) |
| Net cash paid for acquisitions (Note 20) | 5,810 | 899 | 35,151 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2019 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 29, 2019 10-K (Filed: Feb 18, 2020) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 29, 2019 | Dec 30, 2018 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 17,305 | 18,107 |
| Marketable securities (Notes 1 and 2) | 1,982 | 1,580 |
| Accounts receivable trade, less allowances for doubtful accounts $226 (2018, $248) | 14,481 | 14,098 |
| Inventories (Notes 1 and 3) | 9,020 | 8,599 |
| Prepaid expenses and other receivables | 2,392 | 2,699 |
| Assets held for sale (Note 20) | 94 | 950 |
| Total current assets | 45,274 | 46,033 |
| Property, plant and equipment, net (Notes 1 and 4) | 17,658 | 17,035 |
| Intangible assets, net (Notes 1 and 5) | 47,643 | 47,611 |
| Goodwill (Notes 1 and 5) | 33,639 | 30,453 |
| Deferred taxes on income (Note 8) | 7,819 | 7,640 |
| Other assets | 5,695 | 4,182 |
| Total assets | 157,728 | 152,954 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Loans and notes payable (Note 7) | 1,202 | 2,796 |
| Accounts payable | 8,544 | 7,537 |
| Accrued liabilities | 9,715 | 7,601 |
| Accrued rebates, returns and promotions | 10,883 | 9,380 |
| Accrued compensation and employee related obligations | 3,354 | 3,098 |
| Accrued taxes on income (Note 8) | 2,266 | 818 |
| Total current liabilities | 35,964 | 31,230 |
| Long-term debt (Note 7) | 26,494 | 27,684 |
| Deferred taxes on income (Note 8) | 5,958 | 7,506 |
| Employee related obligations (Notes 9 and 10) | 10,663 | 9,951 |
| Long-term taxes payable (Note 8) | 7,444 | 8,242 |
| Other liabilities | 11,734 | 8,589 |
| Total liabilities | 98,257 | 93,202 |
| Shareholders' equity: | ||
| Preferred stock without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 13) | (15,891) | (15,222) |
| Retained earnings | 110,659 | 106,216 |
| Stockholders' Equity before Treasury Stock | 97,888 | 94,114 |
| Less: common stock held in treasury, at cost (Note 12) (487,336,000 shares and 457,519,000 shares) | 38,417 | 34,362 |
| Total shareholders equity | 59,471 | 59,752 |
| Total liabilities and shareholders equity | 157,728 | 152,954 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |